These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7969325

  • 1. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria.
    Milliner DS, Eickholt JT, Bergstralh EJ, Wilson DM, Smith LH.
    N Engl J Med; 1994 Dec 08; 331(23):1553-8. PubMed ID: 7969325
    [Abstract] [Full Text] [Related]

  • 2. Vitamin B6 resistant primary hyperoxaluria type I. Report of 5 cases.
    Streefland M, Donckerwolcke RA.
    Helv Paediatr Acta; 1989 Feb 08; 43(4):313-24. PubMed ID: 2708072
    [Abstract] [Full Text] [Related]

  • 3. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
    Marangella M, Cosseddu D, Petrarulo M, Vitale C, Linari F.
    Nephrol Dial Transplant; 1993 Feb 08; 8(12):1333-7. PubMed ID: 8159301
    [Abstract] [Full Text] [Related]

  • 4. [Primary hyperoxaluria].
    Toussaint C, De Pauw L.
    Nephrologie; 1995 Feb 08; 16(6):399-406. PubMed ID: 8524446
    [Abstract] [Full Text] [Related]

  • 5. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P, Portmann L, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1986 Dec 13; 116(50):1783-6. PubMed ID: 3798070
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS, Wilson DM, Smith LH.
    Kidney Int; 2001 Jan 13; 59(1):31-6. PubMed ID: 11135054
    [Abstract] [Full Text] [Related]

  • 7. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.
    Duffey BG, Alanee S, Pedro RN, Hinck B, Kriedberg C, Ikramuddin S, Kellogg T, Stessman M, Moeding A, Monga M.
    J Am Coll Surg; 2010 Jul 13; 211(1):8-15. PubMed ID: 20610243
    [Abstract] [Full Text] [Related]

  • 8. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.
    Mizusawa Y, Parnham AP, Falk MC, Burke JR, Nicol D, Yamanaka J, Lynch SV, Strong RW.
    Clin Transplant; 1997 Oct 13; 11(5 Pt 1):361-5. PubMed ID: 9361924
    [Abstract] [Full Text] [Related]

  • 9. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL, Nakada SY.
    Urology; 2009 Mar 13; 73(3):484-9. PubMed ID: 19118878
    [Abstract] [Full Text] [Related]

  • 10. Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort.
    van der Hoeven SM, van Woerden CS, Groothoff JW.
    Nephrol Dial Transplant; 2012 Oct 13; 27(10):3855-62. PubMed ID: 22844106
    [Abstract] [Full Text] [Related]

  • 11. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
    Morgan SH, Maher ER, Purkiss P, Watts RW, Curtis JR.
    Nephrol Dial Transplant; 1988 Oct 13; 3(1):28-32. PubMed ID: 3132636
    [Abstract] [Full Text] [Related]

  • 12. Strict blood-pressure control and progression of renal failure in children.
    ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.
    N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals.
    Huang HS, Ma MC, Chen J, Chen CF.
    Neurourol Urodyn; 2003 Oct 22; 22(2):176-82. PubMed ID: 12579636
    [Abstract] [Full Text] [Related]

  • 16. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR.
    Scanning Microsc; 1995 Mar 22; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [Abstract] [Full Text] [Related]

  • 17. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG.
    Surg Obes Relat Dis; 2005 Mar 22; 1(5):481-5. PubMed ID: 16925274
    [Abstract] [Full Text] [Related]

  • 18. An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Tenconi R, Clementi M, Borsatti A.
    N Engl J Med; 1986 Mar 06; 314(10):599-604. PubMed ID: 3945245
    [Abstract] [Full Text] [Related]

  • 19. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
    Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G.
    N Engl J Med; 1994 Mar 31; 330(13):877-84. PubMed ID: 8114857
    [Abstract] [Full Text] [Related]

  • 20. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A.
    Am J Kidney Dis; 2005 Sep 31; 46(3):440-5. PubMed ID: 16129205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.